GLOBAL PATIENT GENERATED HEALTH DATA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Market News

Recent Developments                         

Product Launches

• In January 2023, the World Health Organization (WHO) announced the launch of the publicly accessible global individual patient data (IPD) platform for tuberculosis treatment (TB-IPD), an initiative that will expand the knowledge base for normative guidance on optimal tuberculosis (TB) treatment modalities and stimulate TB research. Over 5,000 TB patients' individual records with treatment results are already stored on this safe platform.
• In October 2022, Panda Health Inc., a digital health marketplace, announced the launch of new categories aimed at assisting hospitals and health systems in providing a full continuum of patient care through health at home programs. The Remote Patient Monitoring (RPM), Hospital at Home, and Telehealth solution categories accessible on Panda's marketplace will range from light-touch virtual visits to more in-depth acute care services in the home.
• In January 2022, Temedica GmbH, a major provider of digital health and data analytics, announced the launch of Permea. Permea is a one-of-a-kind platform that provides medically sound analysis and actionable answers to a wide variety of problems and difficulties that arise throughout the healthcare value chain. Permea gives fresh insights into medicines and their effects in real-world situations for the first time by merging regulatory-grade, patient-generated data with a number of freely available scientific and commercial data sources.

Business Development Activities by Market Players

• In November 2023, AstraZeneca, a global biotechnology company, launched Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators, and patients. With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sectors.
• In March 2023, agilon health, a health care technology company, announced the acquisition of mphrX, a provider of value-based care technology and interoperability solutions. As a result of the transaction, mphrX will become a fully owned subsidiary of agilon health.
• In August 2021, GE Healthcare, a worldwide medical technology company, announced a strategic partnership with Amazon Web Services (AWS), a subsidiary of Amazon that provides on-demand cloud computing platforms, to provide hospitals and healthcare providers with AI and cloud-based imaging solutions, integrated data, and clinical and operational insights. GE Healthcare intends to offer its AI-based imaging applications and Edison Health Services platform on AWS, positioning the company to lead the way in assisting healthcare providers worldwide in transitioning from the traditional care delivery model provided in the hospital setting to a more decentralized, virtual, and distributed model.